NCT02546791View on ClinicalTrials.gov

Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

July 22, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

March 29, 2017

Conditions
Leukemia
Interventions
DRUG

Dasatinib

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02546791 - Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study | Biotech Hunter | Biotech Hunter